(NVMI) Nova - Overview
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: IL0010845571
Stock: Semiconductor Tools, Process Control, Metrology Platforms, Measurement
Total Rating 71
Risk 90
Buy Signal -0.46
| Risk 5d forecast | |
|---|---|
| Volatility | 57.4% |
| Relative Tail Risk | -4.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 53.31 |
| Character TTM | |
|---|---|
| Beta | 2.274 |
| Beta Downside | 0.832 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.79% |
| CAGR/Max DD | 1.58 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: NVMI Nova March 05, 2026
Nova Ltd. (NVMI) develops and sells process control systems for semiconductor manufacturing. These systems are crucial for maintaining quality and efficiency in chip production, a sector experiencing significant growth due to increasing demand for electronic devices.
The companys product line includes metrology platforms that measure dimensions, films, materials, and chemicals at various stages of semiconductor fabrication. This includes critical steps like lithography and etching, which directly impact chip performance and yield.
NVMI serves a broad range of integrated circuit manufacturers, including those in logic, foundry, memory, and advanced packaging. This diversified customer base mitigates risk associated with fluctuations in any single segment of the semiconductor industry.
For more in-depth analysis, further research on ValueRay is recommended.
Headlines to watch out for
- Semiconductor capital expenditure directly impacts equipment demand
- Global chip demand fluctuations affect metrology system sales
- Competition from established metrology providers pressures market share
- Supply chain disruptions increase manufacturing costs
- Geopolitical tensions in Taiwan risk semiconductor production
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 259.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -6.49 > 1.0 |
| NWC/Revenue: 134.7% < 20% (prev 76.40%; Δ 58.31% < -1%) |
| CFO/TA 0.10 > 3% & CFO 245.6m > Net Income 259.2m |
| Net Debt (644.0m) to EBITDA (285.4m): 2.26 < 3 |
| Current Ratio: 6.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.8m) vs 12m ago 5.51% < -2% |
| Gross Margin: 57.37% > 18% (prev 0.58%; Δ 5.68k % > 0.5%) |
| Asset Turnover: 46.95% > 50% (prev 48.36%; Δ -1.41% > 0%) |
| Interest Coverage Ratio: 113.6 > 6 (EBITDA TTM 285.4m / Interest Expense TTM 2.32m) |
Altman Z'' 8.09
| A: 0.50 (Total Current Assets 1.41b - Total Current Liabilities 224.5m) / Total Assets 2.36b |
| B: 0.45 (Retained Earnings 1.06b / Total Assets 2.36b) |
| C: 0.14 (EBIT TTM 263.0m / Avg Total Assets 1.88b) |
| D: 2.28 (Book Value of Equity 2.38b / Total Liabilities 1.04b) |
| Altman-Z'' Score: 8.09 = AAA |
Beneish M -2.75
| DSRI: 0.83 (Receivables 151.9m/140.1m, Revenue 880.6m/672.4m) |
| GMI: 1.00 (GM 57.37% / 57.57%) |
| AQI: 1.31 (AQ_t 0.33 / AQ_t-1 0.26) |
| SGI: 1.31 (Revenue 880.6m / 672.4m) |
| TATA: 0.01 (NI 259.2m - CFO 245.6m) / TA 2.36b) |
| Beneish M-Score: -2.75 (Cap -4..+1) = A |
What is the price of NVMI shares?
As of March 12, 2026, the stock is trading at USD 432.17 with a total of 354,292 shares traded.
Over the past week, the price has changed by -1.32%, over one month by -8.42%, over three months by +29.76% and over the past year by +105.90%.
Over the past week, the price has changed by -1.32%, over one month by -8.42%, over three months by +29.76% and over the past year by +105.90%.
Is NVMI a buy, sell or hold?
Nova has received a consensus analysts rating of 4.57.
Therefore, it is recommended to buy NVMI.
- StrongBuy: 5
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NVMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 501.9 | 16.1% |
| Analysts Target Price | 501.9 | 16.1% |
NVMI Fundamental Data Overview March 08, 2026
P/E Trailing = 51.5451
P/E Forward = 41.6667
P/S = 14.8463
P/B = 10.6417
P/EG = 1.4554
Revenue TTM = 880.6m USD
EBIT TTM = 263.0m USD
EBITDA TTM = 285.4m USD
Long Term Debt = 731.7m USD (from longTermDebt, last quarter)
Short Term Debt = 8.20m USD (from shortTermDebt, last quarter)
Debt = 858.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 644.0m USD (from netDebt column, last quarter)
Enterprise Value = 12.88b USD (13.07b + Debt 858.4m - CCE 1.05b)
Interest Coverage Ratio = 113.6 (Ebit TTM 263.0m / Interest Expense TTM 2.32m)
EV/FCF = 59.12x (Enterprise Value 12.88b / FCF TTM 217.9m)
FCF Yield = 1.69% (FCF TTM 217.9m / Enterprise Value 12.88b)
FCF Margin = 24.75% (FCF TTM 217.9m / Revenue TTM 880.6m)
Net Margin = 29.44% (Net Income TTM 259.2m / Revenue TTM 880.6m)
Gross Margin = 57.37% ((Revenue TTM 880.6m - Cost of Revenue TTM 375.4m) / Revenue TTM)
Gross Margin QoQ = 57.60% (prev 56.73%)
Tobins Q-Ratio = 5.46 (Enterprise Value 12.88b / Total Assets 2.36b)
Interest Expense / Debt = 0.27% (Interest Expense 2.32m / Debt 858.4m)
Taxrate = 11.26% (8.21m / 72.9m)
NOPAT = 233.4m (EBIT 263.0m * (1 - 11.26%))
Current Ratio = 6.28 (Total Current Assets 1.41b / Total Current Liabilities 224.5m)
Debt / Equity = 0.65 (Debt 858.4m / totalStockholderEquity, last quarter 1.32b)
Debt / EBITDA = 2.26 (Net Debt 644.0m / EBITDA 285.4m)
Debt / FCF = 2.96 (Net Debt 644.0m / FCF TTM 217.9m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.82% (Net Income 259.2m / Total Assets 2.36b)
RoE = 22.70% (Net Income TTM 259.2m / Total Stockholder Equity 1.14b)
RoCE = 14.04% (EBIT 263.0m / Capital Employed (Equity 1.14b + L.T.Debt 731.7m))
RoIC = 29.15% (NOPAT 233.4m / Invested Capital 800.6m)
WACC = 13.42% (E(13.07b)/V(13.93b) * Re(14.29%) + D(858.4m)/V(13.93b) * Rd(0.27%) * (1-Tc(0.11)))
Discount Rate = 14.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.78%
[DCF] Terminal Value 65.64% ; FCFF base≈218.2m ; Y1≈269.2m ; Y5≈458.4m
[DCF] Fair Price = 94.17 (EV 3.64b - Net Debt 644.0m = Equity 2.99b / Shares 31.8m; r=13.42% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 77.34 | EPS CAGR: 14.22% | SUE: 0.30 | # QB: 0
Revenue Correlation: 84.91 | Revenue CAGR: 14.51% | SUE: 0.71 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.34 | Chg7d=+0.080 | Chg30d=+0.094 | Revisions Net=+3 | Analysts=7
EPS current Year (2026-12-31): EPS=10.26 | Chg7d=+0.000 | Chg30d=+0.529 | Revisions Net=+5 | Growth EPS=+19.0% | Growth Revenue=+17.3%
EPS next Year (2027-12-31): EPS=12.43 | Chg7d=+0.000 | Chg30d=+0.978 | Revisions Net=+4 | Growth EPS=+21.2% | Growth Revenue=+19.5%
[Analyst] Revisions Ratio: +0.60 (4 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.3% (Discount Rate 14.3% - Earnings Yield 1.9%)
[Growth] Growth Spread = -3.6% (Analyst 8.8% - Implied 12.3%)
P/E Forward = 41.6667
P/S = 14.8463
P/B = 10.6417
P/EG = 1.4554
Revenue TTM = 880.6m USD
EBIT TTM = 263.0m USD
EBITDA TTM = 285.4m USD
Long Term Debt = 731.7m USD (from longTermDebt, last quarter)
Short Term Debt = 8.20m USD (from shortTermDebt, last quarter)
Debt = 858.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 644.0m USD (from netDebt column, last quarter)
Enterprise Value = 12.88b USD (13.07b + Debt 858.4m - CCE 1.05b)
Interest Coverage Ratio = 113.6 (Ebit TTM 263.0m / Interest Expense TTM 2.32m)
EV/FCF = 59.12x (Enterprise Value 12.88b / FCF TTM 217.9m)
FCF Yield = 1.69% (FCF TTM 217.9m / Enterprise Value 12.88b)
FCF Margin = 24.75% (FCF TTM 217.9m / Revenue TTM 880.6m)
Net Margin = 29.44% (Net Income TTM 259.2m / Revenue TTM 880.6m)
Gross Margin = 57.37% ((Revenue TTM 880.6m - Cost of Revenue TTM 375.4m) / Revenue TTM)
Gross Margin QoQ = 57.60% (prev 56.73%)
Tobins Q-Ratio = 5.46 (Enterprise Value 12.88b / Total Assets 2.36b)
Interest Expense / Debt = 0.27% (Interest Expense 2.32m / Debt 858.4m)
Taxrate = 11.26% (8.21m / 72.9m)
NOPAT = 233.4m (EBIT 263.0m * (1 - 11.26%))
Current Ratio = 6.28 (Total Current Assets 1.41b / Total Current Liabilities 224.5m)
Debt / Equity = 0.65 (Debt 858.4m / totalStockholderEquity, last quarter 1.32b)
Debt / EBITDA = 2.26 (Net Debt 644.0m / EBITDA 285.4m)
Debt / FCF = 2.96 (Net Debt 644.0m / FCF TTM 217.9m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.82% (Net Income 259.2m / Total Assets 2.36b)
RoE = 22.70% (Net Income TTM 259.2m / Total Stockholder Equity 1.14b)
RoCE = 14.04% (EBIT 263.0m / Capital Employed (Equity 1.14b + L.T.Debt 731.7m))
RoIC = 29.15% (NOPAT 233.4m / Invested Capital 800.6m)
WACC = 13.42% (E(13.07b)/V(13.93b) * Re(14.29%) + D(858.4m)/V(13.93b) * Rd(0.27%) * (1-Tc(0.11)))
Discount Rate = 14.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.78%
[DCF] Terminal Value 65.64% ; FCFF base≈218.2m ; Y1≈269.2m ; Y5≈458.4m
[DCF] Fair Price = 94.17 (EV 3.64b - Net Debt 644.0m = Equity 2.99b / Shares 31.8m; r=13.42% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 77.34 | EPS CAGR: 14.22% | SUE: 0.30 | # QB: 0
Revenue Correlation: 84.91 | Revenue CAGR: 14.51% | SUE: 0.71 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.34 | Chg7d=+0.080 | Chg30d=+0.094 | Revisions Net=+3 | Analysts=7
EPS current Year (2026-12-31): EPS=10.26 | Chg7d=+0.000 | Chg30d=+0.529 | Revisions Net=+5 | Growth EPS=+19.0% | Growth Revenue=+17.3%
EPS next Year (2027-12-31): EPS=12.43 | Chg7d=+0.000 | Chg30d=+0.978 | Revisions Net=+4 | Growth EPS=+21.2% | Growth Revenue=+19.5%
[Analyst] Revisions Ratio: +0.60 (4 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 12.3% (Discount Rate 14.3% - Earnings Yield 1.9%)
[Growth] Growth Spread = -3.6% (Analyst 8.8% - Implied 12.3%)